{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:27:58Z","timestamp":1761823678088},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mdconsult.com","diseaseamonth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Disease-a-Month"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.disamonth.2014.08.002","type":"journal-article","created":{"date-parts":[[2014,10,4]],"date-time":"2014-10-04T11:13:40Z","timestamp":1412421220000},"page":"483-488","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Multiple myeloma"],"prefix":"10.1016","volume":"60","author":[{"given":"Gautam Raju","family":"Mehta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faten","family":"Suhail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami Y.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghassan","family":"Zalzaleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar V.","family":"Lerma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.disamonth.2014.08.002_bib1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.disamonth.2014.08.002_bib2","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/archinte.158.17.1889","article-title":"Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution","volume":"158","author":"Blad\u00e9","year":"1998","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.disamonth.2014.08.002_bib3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1158\/0008-5472.CAN-07-3096","article-title":"Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance.","volume":"68","author":"Matsui","year":"2008","journal-title":"Cancer Res"},{"issue":"22","key":"10.1016\/j.disamonth.2014.08.002_bib4","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.disamonth.2014.08.002_bib5","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.disamonth.2014.08.002_bib6","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1359\/jbmr.2002.17.11.1921","article-title":"Role of the bone marrow microenvironment in multiple myeloma","volume":"17","author":"Roodman","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"16","key":"10.1016\/j.disamonth.2014.08.002_bib7","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.disamonth.2014.08.002_bib8","first-page":"484","article-title":"Pathogenesis and treatment of myeloma kidney","volume":"124","author":"Sanders","year":"1994","journal-title":"J Lab Clin Med"},{"issue":"4","key":"10.1016\/j.disamonth.2014.08.002_bib9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1081\/JDI-100100888","article-title":"Renal involvement in multiple myeloma: a 10-year study","volume":"22","author":"Sakhuja","year":"2000","journal-title":"Ren Fail"},{"issue":"5","key":"10.1016\/j.disamonth.2014.08.002_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.ackd.2012.06.001","article-title":"Current approach to diagnosis and management of acute renal failure in myeloma patients","volume":"19","author":"Leung","year":"2012","journal-title":"Adv Chronic Kidney Dis"},{"issue":"4","key":"10.1016\/j.disamonth.2014.08.002_bib11","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1172\/JCI119218","article-title":"Localization of a single binding site for immunoglobulin light chains on human Tamm-horsfall glycoprotein","volume":"99","author":"Huang","year":"1997","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.disamonth.2014.08.002_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma.","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"10.1016\/j.disamonth.2014.08.002_bib13","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2215\/CJN.11161111","article-title":"Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases","volume":"7","author":"Leung","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.disamonth.2014.08.002_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0002-9343(84)90781-2","article-title":"Acute renal failure in patients with multiple myeloma","volume":"76","author":"Cohen","year":"1984","journal-title":"Am J Med"},{"issue":"30","key":"10.1016\/j.disamonth.2014.08.002_bib15","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1200\/JCO.2010.28.1238","article-title":"Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study","volume":"28","author":"Ludwig","year":"2010","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.disamonth.2014.08.002_bib16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/0003-4819-143-11-200512060-00005","article-title":"Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial.","volume":"143","author":"Clark","year":"2005","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.disamonth.2014.08.002_bib17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1172\/JCI115629","article-title":"Pathobiology of cast nephropathy from human Bence Jones proteins","volume":"89","author":"Sanders","year":"1992","journal-title":"J Clin Invest"},{"issue":"200","key":"10.1016\/j.disamonth.2014.08.002_bib18","first-page":"473","article-title":"Rehydration in the treatment of severe hypercalcemia","volume":"50","author":"Hosking","year":"1981","journal-title":"QJM"},{"issue":"5","key":"10.1016\/j.disamonth.2014.08.002_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1056\/NEJM198101293040505","article-title":"Calcitonin: physiology and pathophysiology","volume":"304","author":"Austin","year":"1981","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.disamonth.2014.08.002_bib20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/0003-4819-95-2-192","article-title":"Calcitonin as a drug","volume":"95","author":"Deftos","year":"1981","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.disamonth.2014.08.002_bib21","first-page":"1445","article-title":"Clinical review 51: management of hypercalcemia","volume":"77","author":"Bilezikian","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.disamonth.2014.08.002_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/978-3-642-83668-8_3","article-title":"Use of clodronate and calcitonin in hypercalcemia due to malignancy","volume":"116","author":"Ljunghall","year":"1989","journal-title":"Recent Results Cancer Res"},{"issue":"45","key":"10.1016\/j.disamonth.2014.08.002_bib23","first-page":"2375","article-title":"[Human calcitonin in neoplastic hypercalcemia. Results of a prospective randomized trial]","volume":"17","author":"Chevallier","year":"1988","journal-title":"Presse Med"},{"issue":"2","key":"10.1016\/j.disamonth.2014.08.002_bib24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1172\/JCI114459","article-title":"Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro","volume":"85","author":"Carano","year":"1990","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.disamonth.2014.08.002_bib25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/archinte.1985.00360030089018","article-title":"Intravenous etidronate in the management of malignant hypercalcemia","volume":"145","author":"Ryzen","year":"1985","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.disamonth.2014.08.002_bib26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archinte.1991.00400030039007","article-title":"Treatment of hypercalcemia of malignancy with intravenous etidronate. A controlled, multicenter study. The Hypercalcemia Study Group","volume":"151","author":"Singer","year":"1991","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.disamonth.2014.08.002_bib27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.1992.10.1.134","article-title":"Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia","volume":"10","author":"Gucalp","year":"1992","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.disamonth.2014.08.002_bib28","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1001\/archinte.1994.00420170079008","article-title":"Treatment of cancer-associated hypercalcemia. Double-blind comparison of rapid and slow intravenous infusion regimens of pamidronate disodium and saline alone","volume":"154","author":"Gucalp","year":"1994","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1016\/j.disamonth.2014.08.002_bib29","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1210\/jcem.84.10.6026","article-title":"Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy","volume":"84","author":"Rizzoli","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.disamonth.2014.08.002_bib30","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1200\/JCO.2001.19.2.558","article-title":"Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.","volume":"19","author":"Major","year":"2001","journal-title":"J Clin Oncol"},{"issue":"6 suppl 21","key":"10.1016\/j.disamonth.2014.08.002_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/sonc.2002.37417","article-title":"Treatment of hypercalcemia of malignancy with bisphosphonates","volume":"29","author":"Berenson","year":"2002","journal-title":"Semin Oncol"},{"issue":"18","key":"10.1016\/j.disamonth.2014.08.002_bib32","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJMp0907708","article-title":"Lost in transmission\u2014FDA drug information that never reaches clinicians","volume":"361","author":"Schwartz","year":"2009","journal-title":"N Engl J Med"}],"container-title":["Disease-a-Month"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502914001217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502914001217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T17:26:30Z","timestamp":1565889990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011502914001217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0011502914001217"],"URL":"https:\/\/doi.org\/10.1016\/j.disamonth.2014.08.002","relation":{},"ISSN":["0011-5029"],"issn-type":[{"value":"0011-5029","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Disease-a-Month","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.disamonth.2014.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}